Document ID: chunk:federal_register_of_legislation:F2024L01746:clause:2_8
Version: federal_register_of_legislation:F2024L01746
Segment Type: clause
Provision Reference: sch 2 cl 8
Character Range: 14064–14454

8  Schedule 1 (table)
Omit:
Tenofovir with emtricitabine  Tablet containing tenofovir disoproxil maleate 300 mg with emtricitabine 200 mg  Oral  Tenofovir Disoproxil Emtricitabine Viatris 300/200  after 30 April 2024—4 months stock by reference to usual demand of both Tenofovir Disoproxil Emtricitabine Viatris 300/200 and Tenofovir Disoproxil Emtricitabine Mylan 300/200 added together